D-fenfluramine challenge in posttraumatic stress disorder

Biological Psychiatry

Volumn 45, Issue 7, 1999, Pages 928-930

  Davis, Lori L ^a,b   Clark, D Michele ^c   Kramer, Gerald L ^d   Moeller, Frederick G ^e   Petty, Frederick ^c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Anxiety; D fenfluramine; Neuroendocrine; Posttraumatic stress disorder; Prolactin; Serotonin

Indexed keywords

DEXFENFLURAMINE; HYDROCORTISONE; PLACEBO; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; MENTAL DISEASE; NEUROENDOCRINOLOGY; ORAL DRUG ADMINISTRATION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SINGLE BLIND PROCEDURE; SYMPTOMATOLOGY;

ANALYSIS OF VARIANCE; AREA UNDER CURVE; BEHAVIORAL SYMPTOMS; CASE-CONTROL STUDIES; COMBAT DISORDERS; FENFLURAMINE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROLACTIN; SEROTONIN; SEROTONIN AGENTS; SINGLE-BLIND METHOD; SURVIVORS; TIME FACTORS; UNITED STATES; VETERANS; VIETNAM;

EID: 0033120906     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00215-7     Document Type: Article

References (14)

1. Arora R.C., Fichtner C.G., O'Connor F., Crayton J.W. Paroxetine binding in the blood platelets of post-traumatic stress disorder patients. Life Sci. 53:1993;919-928.
2. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., et al. The development of a clinician-administered PTSD scale. J Traumatic Stress. 8:1995;75-90.
3. Brown G., Goodwin F.G., Ballenger J., Goyer P., Major L. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1:1979;131-139.
4. Buss A.H., Durkee A., Baer M.B. An inventory for assessing different kinds of hostility. J Consult Psychol. 21:1957;343-349.
5. Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochraine K., Cooper T.B., et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 46:1989;587-599.
6. Davis L.L., Suris A., Lambert M., Heimberg C., Petty F. PTSD and serotonin New directions for research and treatment . J Psychiatry Neurosci. 22:1997;318-326.
7. Fichtner C.G., O'Connor F.L., Yeoh H.C., Arora R.C., Crayton J.W. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder Associated clinical features . Life Sci. 57:1995;L37-PL44.
8. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
9. Mann J.J., McBride P.A., Malone K.M., Demeo M., Keilp J. Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology. 13:1995;53-64.
10. Mellman T.A., Kumar A.M. Platelet serotonin measures in posttraumatic stress disorder. Psychiatry Res. 53:1994;99-101.
11. Southwick S.M., Yehuda R., Morgan C.A. Clinical studies of neurotransmitter alterations in posttraumatic stress disorder. Friedman M.J., Charney D.S., Deutch A.Y. Neurobiological and Clinical Consequences of Stress. 1995;335-349 Lippincott-Raven, Philadelphia.
12. Southwick S.M., Krystal J.H., Bremner J.D., Morgan C.A., Nicolaou A.L., Nagy L.M., et al. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry. 54:1997;749-758.
13. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview for DSM-IV. 1996;American Psychiatric Press, Washington, DC.
14. Van de Kar L.D. Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu Rev Pharmacol Toxicol. 31:1991;289-320.